Pathogen-Based Therapy — Bacteria Adapted from
▸ Click on the following categories to expand treatment regimens.
▸ Staphylococcus epidermidis
▸ Methicillin-resistant S. aureus
▸ Streptococcus groups A, B, C, G
|
Staphylococcus epidermidis
|
Preferred Regimen
|
▸ Vancomycin 15 mg/kg IV q12h
|
Alternative Regimen
|
▸ TMP-SMX OR
|
|
Staphylococcus aureus, Methicillin sensitive
|
Preferred Regimen
|
▸ Nafcillin 1.5—2 g IV q4h OR ▸ Oxacillin 1.5—2 g IV q4h
|
Alternative Regimen
|
▸ Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL) OR ▸ Linezolid 600 mg IV q12h OR ▸ Daptomycin 6 mg/kg IV q24h
|
Staphylococcus aureus, Methicillin resistant
|
Preferred Regimen
|
▸ Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
|
PLUS
|
▸ Rifampin 600 mg IV q24h
|
Alternative Regimen
|
▸ TMP/SMZ 5 mg/kg IV q6—12h (TMP component) OR ▸ Linezolid 600 mg IV q12h OR ▸ Daptomycin 6 mg/kg IV q24h
|
PLUS
|
▸ Rifampin 600 mg IV q24h
|
|
|